Mizuho Maintains Buy on WAVE Life Sciences, Lowers Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Salim Syed maintains a Buy rating on WAVE Life Sciences (NASDAQ:WVE) but lowers the price target from $13 to $10.
May 24, 2023 | 11:29 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Mizuho analyst maintains Buy rating on WAVE Life Sciences (WVE) but lowers price target from $13 to $10.
The news of Mizuho maintaining a Buy rating on WAVE Life Sciences (WVE) is positive for the stock. However, the lowering of the price target from $13 to $10 may create uncertainty among investors, potentially offsetting the positive impact of the Buy rating. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100